Aopia Biosciences, Inc. is a biotechnology company dedicated to providing revolutionary bioengineering solutions and tools for biomedical research, diagnostics, and therapeutic applications. Their flagship product, Nano EX™, is a next-generation EV isolation platform that offers unparalleled recovery and purity, making it a superior choice for researchers and clinicians. The company differentiates itself through fully automated processing, high scalability, and a commitment to advancing EV-based research and diagnostics. With a strong focus on innovation, Aopia is positioned to lead in the rapidly evolving biotechnology market, particularly in the areas of early disease diagnosis and treatment monitoring.